Cannabis Stocks Rally as Sector Posts Strongest Weekly Performance YTD
Multi-state operators and Canadian LPs surge as institutional investors return to cannabis equities amid improved regulatory outlook and oversold conditions.
Cannabis equities are experiencing their strongest weekly performance of 2024, with the AdvisorShares Pure US Cannabis ETF (MSOS) climbing over 8% through Thursday trading. Multi-state operators including Curaleaf Holdings (CURLF), Green Thumb Industries (GTBIF), and Trulieve Cannabis (TCNNF) are leading the charge, posting double-digit gains as institutional money flows back into the battered sector.
The rally comes after months of sustained selling pressure that pushed cannabis stocks to multi-year lows. MSOS hit its lowest level since inception earlier this month, creating deeply oversold conditions that attracted value-oriented investors. The sector's forward price-to-sales ratios compressed to historic lows, with several MSOs trading below 1x revenue despite maintaining positive cash flows and expanding market share in key states like Florida and New York.
Regulatory momentum is providing additional fuel for the surge. Recent DEA scheduling discussions and growing bipartisan support for banking reform have renewed investor optimism around federal policy changes. The SAFER Banking Act continues to gain traction in Congress, while several states advance adult-use legalization measures ahead of November elections. These developments reduce regulatory overhang that has weighed on cannabis valuations for over two years.
Institutional participation appears to be returning after extended absence from the sector. Options activity has increased significantly, with call volume outpacing puts by the widest margin since early 2023. Several hedge funds have disclosed new positions in leading MSOs, signaling growing confidence in the sector's fundamental trajectory despite ongoing federal restrictions.
The current rally reflects both technical oversold conditions and improving fundamental backdrop for established operators. Cannabis companies have demonstrated resilience through the downturn, with top-tier MSOs maintaining revenue growth and positive EBITDA margins while weaker players exit the market. This consolidation creates opportunities for well-capitalized operators to gain market share and achieve greater operational efficiency as state markets mature.